• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中过表达的白细胞介素-32失调会诱导转移。

Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.

作者信息

Yang Yi, Wang Zihao, Zhou Yiming, Wang Xiaoxiao, Xiang Jianbin, Chen Zongyou

机构信息

Department of General Surgery, Huashan Hospital Affiliated to Fudan University, Floor 16, Building 2, 12 Wulumuqizhong Road, Shanghai, 200040, China.

出版信息

World J Surg Oncol. 2015 Apr 12;13:146. doi: 10.1186/s12957-015-0552-3.

DOI:10.1186/s12957-015-0552-3
PMID:25889282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4414001/
Abstract

BACKGROUND

Interleukin (IL)-32 is a described intracellular pluripotent pro-inflammatory mediator, characterized by the signaling of NF-κB and STAT3.

METHODS

Our study investigated whether IL-32 expression has clinical significance in the metastases of colorectal cancer (CRC). A total of 70 CRC patients were enrolled, 47 cases of which were single CRC organic metastasis lesions while the rest of which were primary CRC lesions (T4NxM0). IL-32 expression was detected by immunohistochemistry, and the correlation between IL-32 expression and CRC metastases was analyzed.

RESULTS

The positive rates of IL-32 in the CRC organic metastasis group were more severe than those in the primary CRC group (P < 0.05). The positive rate of IL-32 in primary CRC with lymph node metastasis was more severe than that of IL-32 in primary CRC without lymph node metastasis (P < 0.05).

CONCLUSIONS

The level of IL-32 expression could influence the N grade of CRC. Thus, IL-32 expression may stimulate the organic metastasis and the lymph node metastasis of CRC.

摘要

背景

白细胞介素(IL)-32是一种已被描述的细胞内多能促炎介质,其特征在于核因子κB(NF-κB)和信号转导与转录激活因子3(STAT3)的信号传导。

方法

我们的研究调查了IL-32表达在结直肠癌(CRC)转移中是否具有临床意义。共纳入70例CRC患者,其中47例为单一CRC器官转移病灶,其余为原发性CRC病灶(T4NxM0)。采用免疫组织化学法检测IL-32表达,并分析IL-32表达与CRC转移之间的相关性。

结果

CRC器官转移组中IL-32的阳性率高于原发性CRC组(P<0.05)。有淋巴结转移的原发性CRC中IL-32的阳性率高于无淋巴结转移的原发性CRC中IL-32的阳性率(P<0.05)。

结论

IL-32表达水平可影响CRC的N分级。因此,IL-32表达可能促进CRC的器官转移和淋巴结转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5007/4414001/bc401e44c0ba/12957_2015_552_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5007/4414001/a81fe6636429/12957_2015_552_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5007/4414001/bc401e44c0ba/12957_2015_552_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5007/4414001/a81fe6636429/12957_2015_552_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5007/4414001/bc401e44c0ba/12957_2015_552_Fig2_HTML.jpg

相似文献

1
Dysregulation of over-expressed IL-32 in colorectal cancer induces metastasis.结直肠癌中过表达的白细胞介素-32失调会诱导转移。
World J Surg Oncol. 2015 Apr 12;13:146. doi: 10.1186/s12957-015-0552-3.
2
Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.Notch1、Jagged1、NF-κB和MMP-9在结直肠癌患者中的免疫组化表达及其与临床病理参数的关系。
Cancer Biomark. 2015;15(6):889-97. doi: 10.3233/CBM-150533.
3
Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.白细胞介素-6在结直肠癌中过表达的临床病理意义
World J Gastroenterol. 2017 Mar 14;23(10):1780-1786. doi: 10.3748/wjg.v23.i10.1780.
4
c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.c-MYC基因拷贝数增加是结直肠癌患者的独立预后因素。
PLoS One. 2015 Oct 1;10(10):e0139727. doi: 10.1371/journal.pone.0139727. eCollection 2015.
5
Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.促动力蛋白1蛋白表达是人类散发性结直肠癌一个有用的新预后因素。
Ann Surg Oncol. 2015 May;22(5):1496-503. doi: 10.1245/s10434-014-4150-3. Epub 2014 Oct 21.
6
Microarray analysis reveals that high mobility group A1 is involved in colorectal cancer metastasis.微阵列分析显示高迁移率族蛋白 A1 参与结直肠癌转移。
Oncol Rep. 2013 Sep;30(3):1488-96. doi: 10.3892/or.2013.2602. Epub 2013 Jul 8.
7
GATA6 predicts prognosis and hepatic metastasis of colorectal cancer.GATA6 可预测结直肠癌的预后和肝转移。
Oncol Rep. 2013 Sep;30(3):1355-61. doi: 10.3892/or.2013.2544. Epub 2013 Jun 19.
8
Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.硒蛋白2表达降低预示着结直肠癌的不良预后。
Oncol Rep. 2015 Mar;33(3):1349-57. doi: 10.3892/or.2014.3701. Epub 2014 Dec 30.
9
HER3 expression in primary colorectal cancer including corresponding metastases in lymph node and liver.HER3在原发性结直肠癌中的表达,包括在淋巴结和肝脏中的相应转移灶。
Acta Oncol. 2015 Apr;54(4):480-6. doi: 10.3109/0284186X.2014.983654. Epub 2015 Jan 20.
10
Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.程序性死亡1通路从原发性结直肠癌向其相应肺转移灶的转变。
J Surg Oncol. 2018 Jun;117(7):1405-1412. doi: 10.1002/jso.25045. Epub 2018 Apr 17.

引用本文的文献

1
Combining Single-Cell RNA Sequencing and Mendelian Randomization to Explore Novel Drug Targets for Parkinson's Disease.结合单细胞RNA测序和孟德尔随机化来探索帕金森病的新型药物靶点
Mol Neurobiol. 2025 Jun;62(6):7380-7392. doi: 10.1007/s12035-025-04700-3. Epub 2025 Jan 31.
2
Role of interleukin‑32 in cancer progression (Review).白细胞介素-32在癌症进展中的作用(综述)
Oncol Lett. 2023 Dec 12;27(2):54. doi: 10.3892/ol.2023.14187. eCollection 2024 Feb.
3
Plasma protein changes reflect colorectal cancer development and associated inflammation.

本文引用的文献

1
Assessing the role of IL-35 in colorectal cancer progression and prognosis.评估白细胞介素-35在结直肠癌进展和预后中的作用。
Int J Clin Exp Pathol. 2013 Aug 15;6(9):1806-16. eCollection 2013.
2
Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: Ras signal inhibition and crosstalk with GM-CSF and IFN-γ.IL-17、22 和 23 在 K-ras 突变患者结直肠癌进展中的差异表达:Ras 信号抑制与 GM-CSF 和 IFN-γ的串扰。
PLoS One. 2013 Sep 6;8(9):e73616. doi: 10.1371/journal.pone.0073616. eCollection 2013.
3
Impact of interleukin-10 gene polymorphisms on survival in patients with colorectal cancer.
血浆蛋白变化反映结直肠癌的发展及相关炎症。
Front Oncol. 2023 May 9;13:1158261. doi: 10.3389/fonc.2023.1158261. eCollection 2023.
4
A Paradoxical Effect of Interleukin-32 Isoforms on Cancer.白细胞介素-32 异构体对癌症的矛盾影响。
Front Immunol. 2022 Feb 25;13:837590. doi: 10.3389/fimmu.2022.837590. eCollection 2022.
5
Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32.靶向TIGIT通过抑制IL-32抑制膀胱癌转移。
Front Pharmacol. 2022 Jan 5;12:801493. doi: 10.3389/fphar.2021.801493. eCollection 2021.
6
Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population.白细胞介素 32 基因多态性 rs12934561 和 rs28372698 与中国汉族人群膀胱癌易感性及预后的相关性。
Dis Markers. 2020 Nov 5;2020:8860445. doi: 10.1155/2020/8860445. eCollection 2020.
7
Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance.食管癌、胃癌和结直肠癌中的局部和全身白细胞介素-32:临床及诊断意义
Diagnostics (Basel). 2020 Oct 4;10(10):785. doi: 10.3390/diagnostics10100785.
8
MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.微小 RNA-29b-3p 通过 IL32/AKT 信号通路抑制口腔鳞状细胞癌细胞迁移和侵袭。
J Cell Mol Med. 2020 Jan;24(1):841-849. doi: 10.1111/jcmm.14794. Epub 2019 Nov 3.
9
Interleukin 32 expression in human melanoma.白细胞介素 32 在人类黑色素瘤中的表达。
J Transl Med. 2019 Apr 5;17(1):113. doi: 10.1186/s12967-019-1862-y.
10
Interleukin-32: Frenemy in cancer?白细胞介素-32:癌症的敌友?
BMB Rep. 2019 Mar;52(3):165-174. doi: 10.5483/BMBRep.2019.52.3.019.
白细胞介素-10 基因多态性对结直肠癌患者生存的影响。
J Korean Med Sci. 2013 Sep;28(9):1302-6. doi: 10.3346/jkms.2013.28.9.1302. Epub 2013 Aug 28.
4
Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals.IL-32β 通过激活淋巴细胞,以及使 NF-κB 和 STAT3 信号失活来发挥抗肿瘤活性。
Cell Death Dis. 2013 May 23;4(5):e640. doi: 10.1038/cddis.2013.166.
5
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
6
Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer.IL-32 的表达调节人食管癌细胞中的 NF-κB 和 p38 MAP 激酶通路。
Cytokine. 2013 Jan;61(1):223-7. doi: 10.1016/j.cyto.2012.09.022. Epub 2012 Oct 26.
7
Meeting the biologic challenge of colorectal metastases.应对结直肠转移的生物学挑战。
Clin Exp Metastasis. 2012 Oct;29(7):821-39. doi: 10.1007/s10585-012-9517-x. Epub 2012 Oct 10.
8
Unravelling the complexity of metastasis - molecular understanding and targeted therapies.解析转移的复杂性 - 分子理解和靶向治疗。
Nat Rev Cancer. 2011 Sep 23;11(10):735-48. doi: 10.1038/nrc3125.
9
IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.白细胞介素 32γ 通过失活 NF-κB 和 STAT3 信号抑制癌细胞生长。
Oncogene. 2011 Jul 28;30(30):3345-59. doi: 10.1038/onc.2011.52. Epub 2011 Mar 21.
10
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.